MOTS-C Australia 10mg / 40mg

MOTS-C is a mitochondrial-derived peptide, distinct from the synthetic analogues that make up most research peptides, studied within Australian peptide research for its role in metabolic signalling.

MOTS-C is written many ways. Mots C, MOTSC, motc and mot c are the everyday forms, and you will see mot c peptide, motc peptide, mot-c peptide, mots-c peptides, mot c peptides and MOTS-C peptide used for the same compound. It also appears as mot-c, m.o.t.s, and is occasionally mistyped mote c, mot cu or motsea. All describe the same mitochondrial-derived peptide.

Mots C peptide is the same compound as MOTS-C. The hyphen is simply dropped in common usage, and it also appears written as MOTSC. All three refer to the mitochondrial-derived peptide PhaseOne supplies in 10mg and 40mg vials for laboratory research use only.

PhaseOne ships MOTS-C Australia-wide for research use, dispatched locally with tracking, in 10mg and 40mg vials. The Certificate of Analysis for each batch, verifying ≥99% HPLC purity, is published in our public COA library.

Yes. MOTS-C is available to buy in Australia from research peptide suppliers such as PhaseOne, supplied as a lyophilised powder for laboratory research. It is not sold through pharmacies or retail outlets, and PhaseOne dispatches Australian orders locally rather than shipping from overseas.

Yes. PhaseOne has MOTS-C peptide for sale online, shipped Australia-wide. Ordering online is the standard route for research peptides in Australia, and every batch has its Certificate of Analysis published in our public COA library so purity can be checked before you order.

The practical test is documentation. Look for a supplier that publishes batch-specific third-party HPLC results rather than a generic purity claim, dispatches within Australia, and states purity as a verified figure. PhaseOne supplies MOTS-C at ≥99% verified purity with a COA for every batch. (!) View our COA library.

PhaseOne prices MOTS-C at A$63.99 for the 10mg vial and A$154.99 for 40mg, and the batch Certificate of Analysis is free to view in our public COA library. Current pricing is shown on this page.

No. MOTS-C is not registered on the ARTG and is not approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock it. It is supplied as a research compound through research suppliers instead.

They are grouped together as metabolic peptides but are mechanistically unrelated. GLP-1 compounds such as Retatrutide and Tirzepatide act on incretin receptors; MOTS-C is encoded in the mitochondrial genome and acts through mitochondrial signalling. (!) Read our MOTS-C vs GLP-1 comparison.

Different categories entirely. CJC-1295 is a GHRH analogue studied on the growth hormone axis, while MOTS-C is a mitochondrial-derived peptide studied in metabolic signalling. PhaseOne supplies both. (!) View our CJC-1295 No DAC.

Laboratory interest in MOTS-C commonly centres on mitochondrial signalling and metabolic regulation research, an emerging area within the broader research peptide field. (!) Explore our metabolic peptide guide.

Unreconstituted MOTS-C should be stored refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.

Each PhaseOne batch is independently verified by third-party HPLC analysis, with the Certificate of Analysis for every batch published in our public COA library.

MOTS-C is supplied in 10mg and 40mg vials, shipped Australia-wide with full batch documentation.

MOTS-C's metabolic signalling research is sometimes considered alongside other longer-chain metabolic peptides such as Retatrutide, though the two have distinct mechanisms. (!) View our Retatrutide.